Abdulrahman Nasiri: Bone Marrow Biopsy Safety on Anticoagulation
Abdulrahman Nasiri, Hematologist, Assistant Professor at Imam Muhammad ibn Saud Islamic University, posted on LinkedIn:
”Honored to be participating in the MENA Hematology Congress 2025 held in Al-Madinah, where I presented our paper titled:
Safety of Bone Marrow Biopsy in Patients Receiving Anticoagulation Therapy
A Systematic Review and Meta-Analysis
This work reviewed more than 65,000 bone marrow biopsy procedures, including over 1,000 anticoagulated patients. The analysis showed that bone marrow biopsy maintains an excellent safety profile, even in patients on anticoagulation, and highlighted the patient-specific factors that truly influence bleeding risk.
Grateful for the opportunity to share this research among distinguished hematologists and researchers across the region.
The congress is still ongoing, and I look forward to the remaining sessions and discussions.
My appreciation to the organizers for a well-executed scientific meeting and to colleagues who enriched the exchange with their insights.”
Stay updated with Hemostasis Today.
-
May 29, 2026, 13:49Tareq Abadl: The Rh Blood Group System – Meet the 5 Antigens That Matter Most
-
May 29, 2026, 13:39Kalyan Roy: Hematopoietic Stem Cell Transplantation in Thalassaemia
-
May 29, 2026, 12:53Wolfgang Miesbach: The Risk of Deskilling in Modern AI Assisted Medicine
-
May 29, 2026, 12:20Pall T. Onundarson: Is Anonymous Peer Review Always Objective
-
May 29, 2026, 11:59Jolene Ng: New Review Explores the Pathophysiology of Pre-Eclampsia
-
May 29, 2026, 11:44Lynne Baird: Why Expanding Bleed Control Kits Across Public Transport Matters
-
May 29, 2026, 11:30Rumbidzai Mushambi: When ‘Just Hormones’ Delays Real Diagnosis
-
May 29, 2026, 09:53Yassin Taher: Recognizing Clonal Eosinophilic Disorders in Pediatric Hypereosinophilic Syndrome
-
May 29, 2026, 09:52Sergio Emanuel Kaiser: Ruvonoflast and a New Anti-Inflammatory Strategy for Residual Cardiovascular Risk